Estrogen Deficiency Clinical Trial
Official title:
Role of Estrogens and Their Receptors in the Development of Skin Tears Evaluated in Residents of Residential Care Facilities.
Background: Skin tears (ST) or "laceration injuries" or "flap wounds" are injuries that are
often found in residents of residential care facilities (RCFs). STs were first defined by
Payne and Martin in 1993 as traumatic wounds, located mainly in the upper limbs, caused by
"shearing, friction or mechanisms combined with the consequent separation of layers of skin.
Skin Tears can cause psychological problems for the patient and represent an economic problem
with important repercussions on both the patient and the community. The etiology suggests
that the physiological changes of the skin related to old age, together with comorbidity, are
among the main risk factors for their onset.
The precise data on the phenomenon are not many, but it is estimated that STs are much more
frequent than the same pressure ulcers, observing prevalence rates in RCFs around 40%
Therefore, there are several risk factors hypothesized so far. Much evidence has correlated,
in various physiological or pathological conditions, the role of estrogens with the functions
and aging of the skin.
Objectives: The project will develop on the analysis of populations of residents from RCFs
belonging to the national territory. Two populations of residents cared in the RCF will be
recruited. A group of subjects suffering from skin tears (group A) and a control group of
subjects without skin tears (group B). The inclusion of patients in both groups will take
place through a simple randomization procedure. Group A patients will be staged according to
the STAR classification for skin tears. For each group a peripheral venous blood sample will
be taken (to measure the levels of estrone and estradiol) and a skin biopsy will be performed
in order to measure estrogen receptors (ERs) expression. A data collection sheet with
angraphic and anamnestic data will be developed to correlate the demographic and comorbidity
data with the clinical conditions of the patients and with the laboratory findings from the
sampling.
Expected results: The primary endpoint will be the correlation between serum estrogen levels,
receptor expression and the presence of skin tears. The secondary endopoint will be
Correlation between receptor structure and clinical staging of skin tears.
Future prospectives: We believe that our study may open new frontiers in the prevention and
in the management of these skin lesions.
BACKGROUND Skin tears were firstly defined by Payne RL and Martin ML, and thereafter by more
recent studies, as traumatic wounds occurring principally on the upper limbs, as a result of
friction alone or shearing and friction forces, which separate the epidermis from the dermis
(partial thickness wounds) or which separate both the epidermis and the dermis from
underlying structures (full thickness wounds). Skin tears are reported to be a common wound
especially on fragile exposed skin, which can be often encountered among older adult,
disabled populations and neonates. Skin tears can be found on all areas of the body and are
particularly common on the extremities. Skin tears may be also very common in public hospital
(PH) inpatients and residents of residential care facilities (RCF) with prevalence up to 41%
in these settings.
Skin Tears can cause psychological problems for the patient and represent an economic problem
with important effects on both the patient and the community.
The risk factors hitherto hypothesized are many and include: advanced age, spasticity or
rigidity, enticement, cognitive decline, long-term drug therapies, inadequate nutritional
intake, etc but none of them, individually and independently, was found to be strongly
correlated onset of skin tears, in such a way as to be able to effectively associate it with
their onset.
Many evidences have correlated, in various physiological or pathological conditions, the role
of estrogens with functions and skin aging.
The serum level of estrogens, and in particular estrone and estradiol, and the peripheral
expression, in the tissues, of the related estrogenic receptors, estrogen α receptors,
estrogen β receptors (ER- α, ER-β) and G protein-coupled estrogen receptor 1 (GPER) may be
related to skin tears.
AIM The aim of the project is to study the correlation between serum estrogen levels and the
expression of the related receptors, with the development of skin tears.
METHODOLOGY The project will develop on the analysis of populations of residents coming from
ACF belonging to the national territory between a minimum of 10 and a maximum of 30. Each RCF
will have to provide a number of subjects between 10 and 40.
The total patient sample will therefore be between a minimum of 100 and a maximum of 1200
subjects.
Therefore, two populations of guests assisted in the RCF will be recruited. A group of
subjects affected by skin tears (group A) and a control group of subjects without skin tears
(group B).
Patients will be included in both groups via a simple randomization procedure. The informed
consent of the patient is required. A group of peripheral venous blood will be made to both
groups to measure the levels of estrone and estradiol and a skin biopsy on the intact skin
area near the lesion in group A and on a thin layer of healthy skin (Shave Biopsy) in the
area of the arm in the control group (group B).
EXPECTED RESULTS Primary Endpoint The primary endpoint will be the correlation between serum
estrogen levels, receptor expression and skin tears.
Secondary Endpoint. Correlation between receptorial structure and clinical staging of skin
tears.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03631680 -
The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause
|
||
Active, not recruiting |
NCT05057546 -
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
|
Phase 4 | |
Completed |
NCT04154306 -
Effects of Fermented Red Clover on Muscle Strength and Muscle Mass
|
N/A | |
Not yet recruiting |
NCT06343870 -
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
|
Phase 3 | |
Recruiting |
NCT06264882 -
Cardiometabolic Consequences of the Loss of Ovarian Function
|
Phase 4 | |
Not yet recruiting |
NCT04245527 -
Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)
|
N/A | |
Completed |
NCT00572858 -
Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women
|
||
Recruiting |
NCT04419727 -
Estrogen Receptors and Peripheral Artery Disease
|
||
Completed |
NCT03018366 -
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
|
Phase 2 | |
Completed |
NCT03112226 -
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
|
N/A | |
Recruiting |
NCT05587920 -
Effect of Oestrogen on Musculoskeletal Outcomes
|
||
Withdrawn |
NCT03856268 -
Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause
|